Filtered By:
Specialty: Pharmaceuticals
Countries: Germany Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 58 results found since Jan 2013.
EU rejects Italian demand to impose Covid curbs on arrivals from China
France, Germany and other states say situation does not warrant change in coronavirus policies
Source: FT.com - Drugs and Healthcare - December 29, 2022 Category: Pharmaceuticals Source Type: news
Man Got 87 Doses Of Covid-19 Coronavirus Vaccines Allegedly In Germany
A 61-year man was trying to collect vaccination record documents so that he could then sell them to anti-vaxxers and others who didn't want to get vaccinated.
Source: Forbes.com Healthcare News - April 4, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news
Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern
Roche and its subsidiary,TibMolbiol, confirm that it has tests for research use that identify the SARS-CoV-2subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and DeltaThe World Health Organization (WHO) has recently reported that the BA.2subvariant is steadily increasing in prevalence, specifically in Denmark Use of these tests assess the spread of circulating variants and can help monitor the potential impact of therapeutics, vaccines and public health interventionsAll Roche SARS-Cov-2 tests correctly identify the virus including these newsubvariantsBasel, 16 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY)...
Source: Roche Investor Update - March 16, 2022 Category: Pharmaceuticals Source Type: news
Roche has rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant
Basel, 3 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and TIB Molbiol, a newly acquired subsidiary within the Roche Diagnostics division, have added three additional Research Use Only (RUO) test kits for the detection of mutations present in the novel B.1.1.529 Omicron SARS-CoV-2 variant: VirSNip SARS Spike ins214EPE (RUO), VirSNiP SARS-CoV-2 Spike S371L S373P (RUO), VirSNip SARS Spike E484A (RUO). The World Health Organization (WHO) has classified the recently emerged SARS-CoV-2 variant, Omicron (B.1.1.529), as a COVID-19 variant of concern (VOC).The VirSNiP variant kits allow differentiation between unique mutation...
Source: Roche Investor Update - December 3, 2021 Category: Pharmaceuticals Source Type: news
Germany Announces Lockdown For Unvaccinated And Could Soon Make Shots Compulsory
A nationwide vaccine mandate could also come into force at the end of February, pending parliamentary approval.
Source: Forbes.com Healthcare News - December 2, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
BioNTech/Pfizer expect new variant impact data 'within 2 weeks'
Germany's BioNTech is studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa.
Source: The Economic Times Healthcare and Biotech News - November 26, 2021 Category: Pharmaceuticals Source Type: news
Covid Surge ‘Worse Than Anything We’ve Seen’: Germany Mulls Tough Restrictions As Europe Targets Unvaccinated With Lockdown, Compulsory Shots
Vaccine holdouts in Austria will soon face a $4,000 fine, while unvaccinated people in Germany, Slovakia and Czechia are barred from public services, events and restaurants.
Source: Forbes.com Healthcare News - November 22, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Policy /policy Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
InnovationRx: Healthcare Price Deflation?; Plus, Germany, France Restrict Moderna Shots Under 30
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - November 10, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick Coronavirus Source Type: news
Germany, France Restrict Moderna ’s Covid Vaccine For Under-30s Over Rare Heart Risk—Despite Surging Cases
Studies indicate the risks of rare heart inflammation following vaccination are very low and much greater for those who contract Covid-19.
Source: Forbes.com Healthcare News - November 10, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
Vitamin A Is Being Studied In The U.K. As A Potential Treatment To Covid Smell Loss
Research from Germany suggests vitamin A nose drops can help people recover from one of the main symptoms of Covid-19, smell loss.
Source: Forbes.com Healthcare News - September 29, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news Coronavirus Source Type: news
Coronavirus latest: US raises travel alert levels for Switzerland, Canada and Germany
Source: FT.com - Drugs and Healthcare - August 30, 2021 Category: Pharmaceuticals Source Type: news
Pfizer And Moderna Rally After FDA Grants Full Approval To Pfizer ’s Covid-19 Vaccine
Pfizer climbed 4%, while its German vaccine partner, BioNTech, soared more than 10%.
Source: Forbes.com Healthcare News - August 23, 2021 Category: Pharmaceuticals Authors: Jonathan Ponciano, Forbes Staff Tags: Investing /investing Money /money Markets /markets Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
Coronavirus latest: Germany to declare whole of Spain ‘risk area’ as Delta variant spreads
Source: FT.com - Drugs and Healthcare - July 9, 2021 Category: Pharmaceuticals Source Type: news
